2 months Should You Buy, Sell or Hold McKesson Before Q2 Earnings? Zacks
MCK’s second-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
X